2025-05-15-Jefferies-邀请-波动市场中的生物技术与医疗技术电话会议；美国东部时间5月16日上午10点_6页_79kb

Biotech vs. Medtech Conference Call Summary

Event Overview

Jefferies is inviting clients to a conference call on Friday, May 16, 2025, at 10:00 AM ET. The call features Senior Healthcare Analysts Michael Yee (Biotech focus) and Matthew Taylor (Medtech focus) discussing current sentiment and outlook for the biotech and medtech sectors. Key topics include recent macro developments such as "Most Favored Nation" drug pricing, FDA regulatory changes, and tariffs.

Key Discussion Points

• Sectors: Biotech and Medtech are analyzed in the context of volatile markets.
• Macro Factors: The talk covers impacts from drug pricing reforms, FDA updates, and global trade tariffs.
• Stocks Provided: A list of relevant tickers is shared, categorized by sector.

Analysts

• Michael Yee: Expert in US large and small-cap equity analysis for biotech.
• Matthew Taylor: Covers US medical supplies and devices.

Ratings and Valuation

Jefferies uses a rating system with Buy, Hold, and Underperform categories, based on expected 12-month total returns. Valuation considers factors like market capitalization, growth, and discounted cash flows. Recent ratings show a majority Buy-rated stocks.

Analyst Certification

All analysts certify that their views reflect personal opinions and that compensation is not tied to report recommendations, though role-based conflicts may exist.

Disclaimer

The report serves as informational guidance only, not personalized advice. Investors should conduct their own research. Market risks, including volatility and currency impacts, are disclosed, and Jefferies has not reviewed all securities for suitability.